首页> 外文期刊>Frontiers in Immunology >A Diverse Repertoire of Human Immunoglobulin Variable Genes in a Chicken B Cell Line is Generated by Both Gene Conversion and Somatic Hypermutation
【24h】

A Diverse Repertoire of Human Immunoglobulin Variable Genes in a Chicken B Cell Line is Generated by Both Gene Conversion and Somatic Hypermutation

机译:通过基因转换和体细胞超突变产生鸡B细胞系中人类免疫球蛋白可变基因的多样性

获取原文
           

摘要

Chicken immune responses to human proteins are often more robust than rodent responses because of the phylogenetic relationship between the different species. For discovery of a diverse panel of unique therapeutic antibody candidates, chickens therefore represent an attractive host for human-derived targets. Recent advances in monoclonal antibody technology, specifically new methods for the molecular cloning of antibody genes directly from primary B cells, has ushered in a new era of generating monoclonal antibodies from non-traditional host animals that were previously inaccessible through hybridoma technology. However, such monoclonals still require post-discovery humanization in order to be developed as therapeutics. To obviate the need for humanization, a modified strain of chickens could be engineered to express a human-sequence immunoglobulin variable region repertoire. Here, human variable genes introduced into the chicken immunoglobulin loci through gene targeting were evaluated for their ability to be recognized and diversified by the native chicken recombination machinery that is present in the B-lineage cell line DT40. After expansion in culture the DT40 population accumulated genetic mutants that were detected via deep sequencing. Bioinformatic analysis revealed that the human targeted constructs are performing as expected in the cell culture system, and provide a measure of confidence that they will be functional in transgenic animals.
机译:鸡对人蛋白质的免疫反应通常比啮齿动物反应更强壮,因为不同物种之间存在系统发育关系。为了发现各种独特的治疗性抗体候选物,鸡代表了人类来源靶标的诱人宿主。单克隆抗体技术的最新进展,特别是直接从原代B细胞直接克隆抗体基因的新方法,已经开创了从非传统宿主动物生产单克隆抗体的新时代,以前无法通过杂交瘤技术来获得。然而,这些单克隆仍需要发现后的人源化才能发展为治疗剂。为了消除对人源化的需求,可以对改良的鸡品系进行改造,使其表达人序列免疫球蛋白可变区谱。在这里,评估了通过基因定位引入鸡免疫球蛋白基因座的人类可变基因被B谱系DT40细胞中存在的天然鸡重组机制识别和多样化的能力。培养扩增后,DT40种群积累了通过深度测序检测到的遗传突变体。生物信息学分析表明,以人为靶标的构建体在细胞培养系统中的运行符合预期,并提供了一定的置信度,可证明它们将在转基因动物中发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号